In vivo micro-PET/CTimaging and biodistributionstudies further corroborated TfR1-dependent tumor uptake, with HT29xenografts displaying pronounced tracer accumulation and high tumor-to-backgroundcontrast, whereas LOVO tumors exhibited minimal uptake. The gene discussed is TFRC; the disease is neoplasm.